2023
ACLP Best Practice Guidance: Evaluation and Treatment of Depression in Solid Organ Transplant Recipients
Zimbrean P, Andrews S, Hussain F, Fireman M, Kuntz K, Niazi S, Simpson S, Soeprono T, Winder G, Jowsey-Gregoire S. ACLP Best Practice Guidance: Evaluation and Treatment of Depression in Solid Organ Transplant Recipients. Journal Of The Academy Of Consultation-Liaison Psychiatry 2023, 64: 357-370. PMID: 37003570, DOI: 10.1016/j.jaclp.2023.03.007.Peer-Reviewed Original ResearchConceptsOrgan transplant recipientsSolid organ transplant recipientsTransplant recipientsDepressive disorderFirst-line antidepressantsTreatment of depressionMental health carePosttransplant depressionSOT recipientsTransplant patientsTreating providerClinical evaluationPositive screeningTreatment interventionsPatientsRecipientsHealth careDepressionDisordersConsensus processFrequent problemSpecial Interest GroupTreatmentPractice guidanceBest practice guidance
2022
Major Depressive Disorder in an International Multisite Wilson Disease Registry
Camarata M, Ala A, Coskun A, Deng Y, Embel V, Gonzalez-Peralta R, Maciejewski K, Patel A, Rubman S, To U, Tomlin R, Schilsky M, Zimbrean P. Major Depressive Disorder in an International Multisite Wilson Disease Registry. Journal Of The Academy Of Consultation-Liaison Psychiatry 2022, 64: 106-117. PMID: 36521682, DOI: 10.1016/j.jaclp.2022.12.001.Peer-Reviewed Original ResearchConceptsMajor depressive disorderWilson's diseaseDepressive disorderLifetime major depressive disorderMental health QOLPhysical health QoLMajor depressive episodeMental health qualityStructured psychiatric evaluationSignificant differencesCross-sectional reportsLiver testsLiver diseaseNeurological assessmentLife scoresClinical correlatesDepressive episodePsychiatric symptomsPsychiatric evaluationDisease RegistrySevere anxietyLaboratory testsLifetime historySignificant associationPatients
2020
P13 Major depressive disorder in patients with wilson’s disease: relationship with liver disease, neurological disease and quality of life
Camarata M, Ala A, Maciejewski K, To U, Zimbrean P, Rubman S, Patel A, Wadhwa A, Coskun A, Apdik T, Tomlin R, Deng Y, Schilsky M. P13 Major depressive disorder in patients with wilson’s disease: relationship with liver disease, neurological disease and quality of life. Gut 2020, 69: a13-a13. DOI: 10.1136/gutjnl-2020-basl.24.Peer-Reviewed Original ResearchMajor depressive disorderQuality of lifeMental health QOLWilson's diseaseNeurological diseasesLiver diseaseDepressive disorderFirst presentationExact testDepression symptomologySeverity of liverLifetime major depressive disorderLiver disease severityFisher's exact testPhysical health QOLSignificant differencesWilcoxon rank sum testMental health problemsRank sum testFIB4 scoreClinical featuresNeurological assessmentPHQ-9PatientsCurrent depressionFRI303 Major depressive disorder in patients with Wilson’s disease: relationship with liver disease, neurological disease and quality of life
Camarata M, Ala A, To U, Zimbrean P, Rubman S, Patel A, Wadhwa A, Maciejewski K, Song X, Deng Y, Tomlin R, Apdik T, Coskun A, Schilsky M. FRI303 Major depressive disorder in patients with Wilson’s disease: relationship with liver disease, neurological disease and quality of life. Journal Of Hepatology 2020, 73: s550-s551. DOI: 10.1016/s0168-8278(20)31573-7.Peer-Reviewed Original Research
2018
Mental Health in Chronic and End-Stage Renal Disease
Zimbrean P, Braverman J, Novak M. Mental Health in Chronic and End-Stage Renal Disease. 2018, 73-89. DOI: 10.1007/978-3-319-94914-7_6.Peer-Reviewed Original ResearchChronic kidney diseaseRenal replacement therapyReplacement therapyPsychiatric presentationsEnd-stage renal diseaseCommon mental health concernsCommon psychiatric presentationsMental health presentationsMental health concernsMental health considerationsRenal diseaseCardiovascular changesKidney diseaseDepressive disorderHealth presentationsHigh prevalenceSleep disordersUS adultsPsychiatric concernsPatientsPsychiatric conditionsAge 20Disease controlHealth concernMental health